BioAtla, Inc. (BCAB) stock

BCABOTCBiological Products, (No Diagnostic Substances)Fiscal year ends December 31

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026Score 4/30

$1.31−0.05 (-3.68%)

Close on Oct 19, 2026Market cap $2.18MP/E –Yield –

BioAtla gross margin

Gross margin is gross profit as a percentage of revenue.

BioAtla has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

See a number that looks wrong?